Hostname: page-component-7c8c6479df-995ml Total loading time: 0 Render date: 2024-03-19T10:55:59.045Z Has data issue: false hasContentIssue false

PRE-ECLAMPSIA AS A MARKER OF CARDIOVASCULAR DISEASE

Published online by Cambridge University Press:  01 November 2008

LA MAGEE
Affiliation:
Departments of Medicine, Vancouver, BC, Canada Obstetrics and Gynaecology, Vancouver, BC, Canada Health Care and Epidemiology, Vancouver, BC, Canada Child and Family Research Institute of British Columbia, University of British Columbia, Vancouver, BC, Canada British Columbia's Women's Hospital and Health Centre, Vancouver, BC, Canada
J NEWSTEAD
Affiliation:
Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
J NG
Affiliation:
Departments of Medicine, Vancouver, BC, Canada
AM CÔTÉ
Affiliation:
Department of Nephrology, University of Sherbrooke, Sherbrooke, Quebec, Canada.
P VON DADELSZEN
Affiliation:
Obstetrics and Gynaecology, Vancouver, BC, Canada Health Care and Epidemiology, Vancouver, BC, Canada Child and Family Research Institute of British Columbia, University of British Columbia, Vancouver, BC, Canada British Columbia's Women's Hospital and Health Centre, Vancouver, BC, Canada

Extract

Cardiovascular disease is the leading cause of death in women. The hypertensive disorders of pregnancy (HDP) are the most common medical complication of pregnancy, complicating up to 10% of pregnancies worldwide. They represent a leading cause of maternal mortality and morbidity in pregnancy. The most common of these disorders is gestational hypertension (5–6%). Using population-based data, approximately 1% of pregnancies are complicated by pre-existing hypertension, 5–6% by gestational hypertension without proteinuria, and 1–2% by pre-eclampsia.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCE

1Mosca, L, Appel, LJ, Benjamin, EJ, Berra, K, Chandra-Strobos, N, Fabunmi, RP et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109 (5): 672–93.Google Scholar
2Allen, VM. The effect of hypertensive disorders in pregnancy on perinatal outcomes: a population-based cohort study. Ottawa: National Library of Canada, 2002.Google Scholar
3Bellamy, L, Casas, JP, Hingorani, AD, Williams, DJ. Pre-eclampsia and the risk of cardiovascular disease and cancer in later life: a systematic review and meta-analysis. Br Med J 2007; 335: 974.Google Scholar
4Ray, JG, Vermeulen, MJ, Schull, MJ, Redelmeier, DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366: 17971803.Google Scholar
5Ridker, PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813–818.Google Scholar
6Magnussen, EB, Vatten, LJ, Lund-Nilsen, TI, Salvesen, KA, Davey, SG, Romundstad, PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. Br Med J 2007; 335: 978.Google Scholar
7Pilote, L, Dasgupta, K, Guru, V, Humphries, KH, McGrath, J, Norris, C et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007; 176: S144.Google Scholar
8Yusuf, S, Hawken, S, Ounpuu, S, Dans, T, Avezum, A, Lanas, F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52.Google Scholar
9American Diabetes Association. Standards od Medical Care in Diabetes. Diabetes Care 2004; 27 (supp1): S15S35.Google Scholar
10Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2003; 27 (suppl2): S1–S152.Google Scholar
11K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl 1): S1266.Google Scholar
12KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kid Dis 2007; 49 (2 SUPPL 2): S12S154.Google Scholar
13de Jong, PE, Curhan, GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol 2006; 17: 2120–126.Google Scholar
14Weir, MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007; 2: 581–90.Google Scholar
15Padwal, RJ, Hemmelgarn, BR, Khan, NA, Grover, S, McAlister, FA, McKay, DW et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2008; 24: 455–63.Google Scholar
16Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green, LA, Izzo, JL Jr. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–572.Google Scholar
17Mancia, G, De, BG, Dominiczak, A, Cifkova, R, Fagard, R, Germano, G et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–187.Google Scholar
18Chesley, LC, Annitto, JE, Cosgrove, RA. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1978; 124: 446–59.Google Scholar
19Hannaford, P, Ferry, S, Hirsch, S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997; 77: 154–58.Google Scholar
20Wikstrom, AK, Haglund, B, Olovsson, M, Lindeberg, SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005; 112: 1486–491.Google Scholar
21Sattar, N, Greer, IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med 2002; 325 (7356): 157160.Google Scholar
22Vikse, BE, Irgens, LM, Leivestad, T, Skjaerven, R, Iversen, BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359: 800809.Google Scholar
23Ness, RB, Hubel, CA. Risk for coronary artery disease and morbid preeclampsia: a commentary. Ann Epidemiol 2005; 15: 726–33.Google Scholar
24Rodie, VA, Freeman, DJ, Sattar, N, Greer, IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004; 175: 189202.Google Scholar
25James, PR, Nelson-Piercy, C. Management of hypertension before, during, and after pregnancy. Heart 2004; 90: 1499–504.Google Scholar
26von Dadelszen, P, Magee, LA, Krajden, M, Alasaly, K, Popovska, V, Devarakonda, RM et al. Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG 2003; 110: 725–30.Google Scholar
27von Dadelszen, P, Magee, LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obst Gynecol Scand 2002; 81: 642–48.Google Scholar
28De Wolf, F, Robertson, WB, Brosens, I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975; 123: 164–74.Google Scholar
29Roberts, JM, Gammill, HS. Preeclampsia: recent insights. Hypertension 2005; 46: 1243–249.Google Scholar
30Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–421.Google Scholar
31Feldman, R, Genest, J. Global risk assessment in 2005: Where do we stand? Expert Opin: Clinical Impact 2005; 3–5.Google Scholar
32Smith, GN, Walker, MC, Liu, A, Wen, SW, Swansburg, M, Ramshaw, H et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2008.Google Scholar
33Grover, SA, Lowensteyn, I, Joseph, L, Kaouache, M, Marchand, S, Coupal, L et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial. Arch Intern Med 2007; 167: 2296–303.Google Scholar
34Grady, D, Herrington, D, Bittner, V, Blumenthal, R, Davidson, M, Hlatky, M et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 4957.Google Scholar
35Rossouw, JE, Prentice, RL, Manson, JE, Wu, L, Barad, D, Barnabei, VM et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465–477.Google Scholar
36Chobanian, AV, Bakris, GL, Black, HR, Cushman, WC, Green, LA, IzzoJL, Jr. JL, Jr. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–572.Google Scholar
37Cifkova, R, Erdine, S, Fagard, R, Farsang, C, Heagerty, AM, Kiowski, W et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21: 1779–786.Google Scholar
38Khan, NA, Hemmelgarn, B, Herman, RJ, Rabkin, SW, McAlister, FA, Bell, CM et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 – therapy. Can J Cardiol 2008; 24: 465–75.Google Scholar
39Padwal, RJ, Hemmelgarn, BR, Khan, NA, Grover, S, McAlister, FA, McKay, DW et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2008; 24: 455–63.Google Scholar
40Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–421.Google Scholar
41Genest, J, Frohlich, J, Fodor, G, McPherson, R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 2003; 169: 921–24.Google Scholar
42Barden, AE, Beilin, LJ, Ritchie, J, Walters, BN, Michael, C.Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 1999; 17 (9): 13071315.Google Scholar
43Forest, JC, Girouard, J, Masse, J, Moutquin, JM, Kharfi, A, Ness, RB et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005; 105: 1373–380.Google Scholar
44Girouard, J, Giguere, Y, Moutquin, JM, Forest, JC. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007; 49: 10561062.Google Scholar
45Manten, GT, Sikkema, MJ, Voorbij, HA, Visser, GH, Bruinse, HW, Franx, A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2007; 26: 3950.Google Scholar
46Rosing, U, Samsioe, G, Olund, A, Johansson, B, Kallner, A. Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia. Horm Metab Res 1989; 21: 376–82.Google Scholar
47Johnson, C. Pregnancy healthy weights initiative. British Columbia Perinatal Health Program – Perinatal database registry 2007.Google Scholar
48Lau, DC, Douketis, JD, Morrison, KM, Hramiak, IM, Sharma, AM, Ur, E.2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007; 176: S113.Google Scholar
49Broedl, UC, Geiss, HC, Parhofer, KG. Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy. J Gen Intern Med 2003; 18: 190–95.Google Scholar
50Campbell, NR, Khan, NA, Grover, SA. Barriers and remaining questions on assessment of absolute cardiovascular risk as a starting point for interventions to reduce cardiovascular risk. J Hypertens 2006; 24: 1683–685.Google Scholar
51Scialli, AR, Lione, A. ACE inhibitors and major congenital malformations. N Engl J Med 2006; 355: 1280.Google Scholar
52ClappJF, III JF, III, Kim, H, Burciu, B, Lopez, B. Beginning regular exercise in early pregnancy: effect on fetoplacental growth. Am J Obstet Gynecol 2000; 183: 1484–488.Google Scholar
53Villamor, E, Cnattingius, S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet 2006; 368: 1164–170.Google Scholar
54Patel, JA, Colella, JJ, Esaka, E, Patel, NA, Thomas, RL. Improvement in infertility and pregnancy outcomes after weight loss surgery. Med Clin North Am [Review]. 2007; 91: 515–28.Google Scholar
55ACOG committee opinion. Number 319, October 2005. The role of obstetrician-gynecologist in the assessment and management of obesity. Obstet Gynecol 2005; 106: 895–99.Google Scholar
56Amorim, AR, Linne, YM, Lourenco, PM. Diet or exercise, or both, for weight reduction in women after childbirth. Cochrane Database Syst Rev 2007; 3: CD005627.Google Scholar
57Hill, JO, Thompson, H, Wyatt, H. Weight maintenance: what's missing? J Am Diet Assoc 2005; 105 (5 Suppl 1): S63S66.Google Scholar
58Bravata, DM, Sanders, L, Huang, J, Krumholz, HM, Olkin, I, Gardner, CD et al. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 2003; 289: 1837–850.Google Scholar
59Rosenstock, IM. Adoption and maintenance of lifestyle modifications. Am J Prev Med 1988; 4: 349–52.Google Scholar
60Power, ML, Cogswell, ME, Schulkin, J. Obesity prevention and treatment practices of U.S. obstetrician-gynecologists. Obstet Gynecol 2006; 108: 961–68.Google Scholar
61MacDonald, SE, Walker, M, Ramshaw, H, Godwin, M, Chen, XK, Smith, G. Hypertensive disorders of pregnancy and long-term risk of hypertension: what do Ontario prenatal care providers know, and what do they communicate? J Obstet Gynaecol Can 2007; 29: 705–10.Google Scholar
62Mosca, L, Linfante, AH, Benjamin, EJ, Berra, K, Hayes, SN, Walsh, BW et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499510.Google Scholar
63Huang, J, Yu, H, Marin, E, Brock, S, Carden, D, Davis, T. Physicians' weight loss counseling in two public hospital primary care clinics. Acad Med 2004; 79: 156–61.Google Scholar
64Prochaska, JO, Diclemente, CC. Stages of change in the modification of problem behaviors. Prog Behav Modif 1992; 28: 183–18.Google Scholar
65Geller, J, Drab-Hudson, DL, Whisenhunt, BL, Srikameswaran, S. Readiness to change dietary restriction predicts outcomes in the eating disorders. Eat Disord 2004; 12: 209–24.Google Scholar
66Tamaki, J, Yoshita, K, Kikuchi, Y, Takebayashi, T, Chiba, N, Okamura, T et al. Applicability of the stages of change model for analyzing fruit and vegetable intake in relation to urinary potassium excretion: baseline results from the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. Hypertens Res 2004; 27: 843–50.Google Scholar
67Windhauser, MM, Ernst, DB, Karanja, NM, Crawford, SW, Redican, SE, Swain, JF et al. Translating the Dietary Approaches to Stop Hypertension diet from research to practice: dietary and behavior change techniques. DASH Collaborative Research Group. J Am Diet Assoc 1999; 99: S90S95.Google Scholar
68Tulman, L, Fawcett, J, Groblewski, L, Silverman, L. Changes in functional status after childbirth. Nurs Res 1990; 39: 7075.Google Scholar
69Wee, CC, Davis, RB, Phillips, RS. Stage of readiness to control weight and adopt weight control behaviors in primary care. J Gen Intern Med 2005; 20: 410–15.Google Scholar
70Rosentock, IM. Historical originas of the health belief model. Health Ed Monogr 1974; 2: 328–33.Google Scholar
71Stotts, AL, Diclemente, CC, Carbonari, JP, Mullen, PD. Pregnancy smoking cessation: a case of mistaken identity. Addict Behav 1996; 21: 459–71.Google Scholar
72Passehl, B, McCarroll, C, Buechner, J, Gearring, C, Smith, AE, Trowbridge, F. Preventing childhood obesity: establishing healthy lifestyle habits in the preschool years. J Pediatr Health Care 2004; 18: 315–19.Google Scholar
73Keller, C, Allan, J, Tinkle, MB. Stages of change, processes of change, and social support for exercise and weight gain in postpartum women. J Obstet Gynecol Neonatal Nurs 2006; 35: 232–40.Google Scholar
74Ali, Z, Alexis, SD. Occurrence of diabetes mellitus after gestational diabetes mellitus in Trinidad. Diabetes Care 1990; 13: 527–29.Google Scholar
75Kaufmann, RC, Schleyhahn, FT, Huffman, DG, Amankwah, KS. Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am J Obstet Gynecol 1995; 172: 621–25.Google Scholar
76Feig DS, , Chen, E, Naylor, CD. Self-perceived health status of women three to five years after the diagnosis of gestational diabetes: a survey of cases and matched controls. Am J Obstet Gynecol 1998; 178: 386–93.Google Scholar
77Gunderson, EP, Rifas-Shiman, SL, Oken, E, Rich-Edwards, JW, Kleinman, KP, Taveras, EM et al. Association of fewer hours of sleep at 6 months postpartum with substantial weight retention at 1 year postpartum. Am J Epidemiol 2008; 167: 178–87.Google Scholar
78Reproductive Mental Health Guidelines 3: Identification and Assessment of reproductive mental illness during the preconception and perinatal perios. BCRCP 2003.Google Scholar
79Carter, AS, Baker, CW, Brownell, KD. Body mass index, eating attitudes, and symptoms of depression and anxiety in pregnancy and the postpartum period. Psychosom Med 2000; 62: 264–70.Google Scholar
80Harris, HE, Ellison, GT, Clement, S. Do the psychosocial and behavioral changes that accompany motherhood influence the impact of pregnancy on long-term weight gain? J Psychosom Obstet Gynaecol 1999; 20: 6579.Google Scholar
81Pereira, MA, Rifas-Shiman, SL, Kleinman, KP, Rich-Edwards, JW, Peterson, KE, Gillman, MW. Predictors of change in physical activity during and after pregnancy: Project Viva. Am J Prev Med 2007; 32: 312–19.Google Scholar
82Setse, R, Grogan, R, Cooper, LA, Strobino, D, Powe, NR, Nicholson, W. Weight loss programs for urban-based, postpartum African-American women: perceived barriers and preferred components. Matern Child Health J 2008; 12: 119–27.Google Scholar
83Fraser, AB, Grimes, DA. Effect of lactation on maternal body weight: a systematic review. Obstet Gynecol Surv 2003; 58: 265–69.Google Scholar
84Fowles, ER, Walker, LO. Correlates of dietary quality and weight retention in postpartum women. J Community Health Nurs 2006; 23: 183–97.Google Scholar
85Devine, CM, Bove, CF, Olson, CM. Continuity and change in women's weight orientations and lifestyle practices through pregnancy and the postpartum period: the influence of life course trajectories and transitional events. Soc Sci Med 2000; 50: 567–82.Google Scholar
86Teixeira, PJ, Going, SB, Houtkooper, LB, Cussler, EC, Metcalfe, LL, Blew, RM et al. Pretreatment predictors of attrition and successful weight management in women. Int J Obes Relat Metab Disord 2004; 28: 1124–133.Google Scholar
87Miller, TD, Balady, GJ, Fletcher, GF. Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Ann Behav Med 1997; 19: 220–29.Google Scholar
88Symons, DD, Hausenblas, HA. Women's exercise beliefs and behaviors during their pregnancy and postpartum. J Midwifery Womens Health 2004; 49: 138–44.Google Scholar
89Burke, V, Mori, TA, Giangiulio, N, Gillam, HF, Beilin, LJ, Houghton, S et al. An innovative program for changing health behaviours. Asia Pac J Clin Nutr 2002; 11 Suppl 3: S586S597.Google Scholar
90Fang, WL, Goldstein, AO, Butzen, AY, Hartsock, SA, Hartmann, KE, Helton, M et al. Smoking cessation in pregnancy: a review of postpartum relapse prevention strategies. J Am Board Fam Pract 2004; 17: 264–75.Google Scholar
91Feig, DS, Zinman, B, Wang, X, Hux, JE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 2008; 179: 229–34.Google Scholar
92Gillies, CL, Abrams, KR, Lambert, PC, Cooper, NJ, Sutton, AJ, Hsu, RT et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J 2007; 334: 299.Google Scholar
93Eddy, DM, Schlessinger, L, Kahn, R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 2005; 143: 251–64.Google Scholar
94Tuomilehto, J, Lindstrom, J, Eriksson, JG, Valle, TT, Hamalainen, H, Ilanne-Parikka, P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–350.Google Scholar
95Kahn, R, Robertson, RM, Smith, R, Eddy, D. The impact of prevention on reducing the burden of cardiovascular disease. Circulation 2008; 118: 576585.Google Scholar